AzTrials
AzTrials

LonelinessNCT04577911

How is Social Connection Represented in the Brain?

An observational study of Loneliness, run by Columbia University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Nearly half of the U.S. population sometimes or always experiences loneliness, which is alarming given that loneliness confers risk for negative mental and physical health outcomes. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Loneliness
What is being tested?
Basic Science Experiment
How many people
248 participants
Where
1 siteUnited States
Study dates
1 Apr 2021to Nov 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants will be between the ages of 18 and 65

Who may be able to join

  • safe for MRI scanning
  • not taking psychiatric medication

Who cannot join

  • not safe for MRI scanning
  • taking psychiatric medication

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Meghan L Meyer, PhD contact

650-521-1701

mlm2378@columbia.edu

United States1 site, 1 recruiting
  • Columbia University Irving Medical Center

    New York, New York, 10032

    Meghan L Meyer, PhD, 650-521-1701

    Recruiting

Other trials in United States

About this study

Official title: Using the Brain to Reveal Mental Representations of Subjective Connection

Nearly half of the U.S. population sometimes or always experiences loneliness, which is alarming given that loneliness confers risk for negative mental and physical health outcomes. Extensive research suggests loneliness is characterized by subjective isolation: many lonely individuals maintain a number of relationships but still report feeling lonely. The goal of this proposal is to use functional magnetic resonance imaging to reveal how the brain represents our subjective connection to and isolation from other people, which will ultimately inform optimal ways to intervene to reduce loneliness.

Read the detailed description

Extensive research suggests loneliness is characterized by subjective isolation: many lonely individuals maintain a number of relationships but still report feeling lonely. Thus, a neurobiological account of loneliness requires that we understand how the brain represents subjective connections to others and how loneliness alters these representations. The long-term goal of this proposal is to identify how subjective isolation is represented in the brain in order to identify novel ways to intervene on this representation to attenuate loneliness. This study proposes that the brain organizes representations of people based on subjective connection to them, and that loneliness systematically alters this organization. The Specific Aim 1 will determine whether subjective closeness organizes self and other representations in the brain. While undergoing fMRI, participants will complete tasks in which they reflect on themselves and other people. They will also report on their subjective closeness to the other people. The study will test whether the brain organizes mental representations of the self and one's own social network members based on subjective closeness. The Specific Aim 2 will determine how loneliness modulates self and other representations in the brain. The Specific, Exploratory Aim 3 will determine the cognitive consequences of altered self and other representation in loneliness. The proposal of this study is imperative for ultimately revealing neurocognitive mechanisms to intervene on to reduce loneliness.

Conditions
Loneliness
Being tested
Basic Science Experiment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Basic Science ExperimentOther

    participants complete cognitive tasks while undergoing functional magnetic resonance imaging (fMRI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood Oxygenated-Level Dependent (BOLD) Response

    Measured: 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2020
  2. Study start1 Apr 2021
  3. Primary completionNov 2026 (estimated)
  4. Study completionNov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
248 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04577911
Sponsor's protocol ID
AAAU7311
Other IDs
1R01MH125406-01
Status last verified
Dec 2025
First submitted
30 Sep 2020
Last updated
16 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Loneliness, run by Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Meghan L Meyer, PhD (650-521-1701, mlm2378@columbia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood Oxygenated-Level Dependent (BOLD) Response (time frame: 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in